ScanSource director granted 3,234 shares of stock

ScanSource director Jeffrey R. Rodek received an equity grant of 3,234 common shares, increasing his direct holdings to 33,227 shares.

Rhea-AI Filing Summary

SCANSOURCE, INC. (SCSC) reported that director Jeffrey R. Rodek received a grant of 3,234 shares of common stock on September 1, 2026, classified as a grant, award, or other acquisition at a reported price of $0.00 per share. Following this equity award, he directly holds 33,227 shares of ScanSource common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 3,234 shares

Grant/Award 1 txn

Insider RODEK JEFFREY R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,234	$0.00	$0.00

Holdings After Transaction: Common Stock — 33,227 shares (Direct)

Key Figures

Shares granted: 3,234 shares Price per share: $0.00 per share Shares held after transaction: 33,227 shares +1 more

4 metrics

Shares granted 3,234 shares Equity grant of common stock to director on September 1, 2026

Price per share $0.00 per share Reported for the 3,234-share grant classified as a grant, award, or other acquisition

Shares held after transaction 33,227 shares Director Jeffrey R. Rodek’s direct holdings after the September 1, 2026 grant

Non-derivative transactions acquiring 1 transaction One acquisition-type non-derivative transaction reported in this Form 4

Key Terms

Common Stock, Grant, award, or other acquisition, direct

3 terms

Common Stock financial

"The security involved is listed as Common Stock in the report"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"The transaction code description is Grant, award, or other acquisition"

direct financial

"Ownership type for the reported shares is classified as direct"

FAQ

What insider transaction did SCSC director Jeffrey R. Rodek report?

Director Jeffrey R. Rodek reported a grant of 3,234 shares of ScanSource common stock on September 1, 2026, classified as a grant, award, or other acquisition, received at a reported price of $0.00 per share as part of his equity compensation.

How many SCSC shares does Jeffrey R. Rodek hold after this transaction?

After the September 1, 2026 equity grant, Jeffrey R. Rodek directly holds 33,227 shares of ScanSource common stock, according to the reported post-transaction holdings figure.

Was the SCSC insider transaction made under a Rule 10b5-1 trading plan?

No. The report indicates the Rule 10b5-1 trading plan checkbox is not affirmed, meaning the September 1, 2026 equity grant to Jeffrey R. Rodek is not reported as made under a Rule 10b5-1 trading plan.

What type of security did Jeffrey R. Rodek acquire from SCSC?

Jeffrey R. Rodek acquired Common Stock of ScanSource, Inc. The transaction involved 3,234 shares of the company’s common stock, reported as a non-derivative equity award.

Did Jeffrey R. Rodek buy or sell any SCSC shares on the market?

No market purchases or sales are reported. The Form 4 shows only a grant/award acquisition of 3,234 shares at a reported price of $0.00 per share, with no open-market buys or sells.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:02 PM Accepted by SEC EDGAR 09/03/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RODEK JEFFREY R

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SOUTH CAROLINA 29615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		3,234	A	$0.00	33,227	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	J. Creighton Lynes, attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)